Company / Current Assets per Share
NEKTAR THERAPEUTICS Current Assets per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$21.50
FY2025
5-year range
$1.37 / $21.50
FY2021-FY2025
Trend
+1474.7%
vs FY2024
Sector context
#27 of 210
Health Care
What the data says
Current Assets per Share changed +1475% YoY in FY2025, a notable deviation from the 9-year average annual change of +179%.
Based on SEC 10-K filings.
21.50 in FY2025 with a 5-year CAGR of +27.2%. Top quartile in the Health Care sector.
Improved from $1.75 to $21.50 over the past 2 years.
Health Care sector context is included.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- +94.0%
- 5-Year CAGR
- +27.2%
- 10-Year CAGR
- -
Sector benchmark
Top 13% in Health CareTop 13% of 210This company $21.50 Sector average $134.38
▼
-84.0% below sector average
Key checks
Key Insights
- In FY2025, current assets per share increased 1474.7% year-over-year.
- Ranks #27 out of 210 companies in the Health Care sector.
- Lowest current assets per share in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score -11.97 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $21.50 | +1474.7% |
| FY2024 | $1.37 | -22.2% |
| FY2023 | $1.75 | -40.4% |
| FY2022 | $2.94 | -33.4% |
| FY2021 | $4.42 | -31.5% |
| FY2020 | $6.45 | -21.3% |
| FY2019 | $8.19 | -9.1% |
| FY2018 | $9.01 | +322.5% |
| FY2017 | $2.13 | -32.3% |
| FY2016 | $3.15 | +18.1% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026